Pathogenic DDX41 variants, possible response predictors to low-dose melphalan in hypo- and normocellular MDS and AML.
Otto Emil NyquistJakob DalgaardSigne SpetalenSynne TorkildsenHege FrøenEivind GaltelandOle KlungsøyrAstrid BergremCamilla VoHjalmar SørbøBirgitte EikenHedda LerdalAnn-Karin SolvangHilde JensvollTatjana PandzicPanagiotis BaliakasIngunn DybedalPublished in: British journal of haematology (2023)